Withdrawal symptoms during therapy with transdermal fentanyl (fentanyl TTS)?
Zenz
M
M
Department of Anesthesiology, University Hospital Bergmannsheil, Bochum, Germany.
Donner
B
B
Strumpf
M
M
D000279:Administration, Cutaneous; D000328:Adult; D003110:Colonic Neoplasms / Q000503:physiopathology*; D005260:Female; D005283:Fentanyl / Q000008:administration & dosage* / Q000009:adverse effects*; D006801:Humans; D008875:Middle Aged; D009020:Morphine / Q000627:therapeutic use; D009362:Neoplasm Metastasis; D010051:Ovarian Neoplasms / Q000503:physiopathology*; D010148:Intractable Pain / Q000188:drug therapy*; D010166:Palliative Care; D012008:Recurrence; D013375:Substance Withdrawal Syndrome
D009020:Morphine; D005283:Fentanyl